Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
about
Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosisNew and emerging disease modifying therapies for multiple sclerosisDevelopment of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approachOverview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.Toxicities of immunosuppressive treatment of autoimmune neurologic diseases.Fingolimod for relapsing multiple sclerosis: an update.A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.Treatment of multiple sclerosis: current concepts and future perspectives.Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.Emerging oral drugs for relapsing-remitting multiple sclerosis.Tumefactive demyelination: an approach to diagnosis and management.Fingolimod for the treatment of relapsing multiple sclerosis.Reversible cerebral vasoconstriction syndrome in association with fingolimod use.Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events.Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patientsNeurological safety of fingolimod: An updated review[Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system].Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.Differential effects of fingolimod on B-cell populations in multiple sclerosis.
P2860
Q21146659-BAA51A1A-6AF0-4857-A908-2CB52216A397Q22242305-FC0C87C5-80F0-4EFC-90A0-2CAE159F8961Q22305854-E5DF2F0C-DCC3-47E1-9F54-C55F9E44CC26Q30458371-2F378614-6B89-4963-8084-D7607FD12A54Q34257903-FCEB4E99-E2BF-4501-838C-2C20A0EF2A15Q34618474-0BB807E1-9617-4876-9E47-4CD48E84BE81Q35953902-96CBD3C5-0A10-4B14-BA25-3A44627BAD71Q36664563-FAAE101A-9AEC-47E9-82EE-F103001A3B6EQ37884434-52DFFE5A-BFFD-4F77-8B5A-A7328FDF493DQ37905767-71BE1F9A-7FA5-434B-B459-EF4CCA63272AQ37965547-D852BC42-A975-4787-B2B6-EA4EBFE5A88EQ38075462-59797CAB-99AC-473F-9413-42DA08EF2348Q38112209-A5E1B13E-9802-44D4-98A3-1F72AD74AF78Q39000688-E8946690-EB95-48FB-A469-FCDC812EA12CQ39320418-8012876D-443A-4DAE-98B2-EB997D40FAC1Q41021726-F070B7FB-576E-4211-8B50-DDE32F20E24CQ41553443-D507989C-DB92-47F0-9D39-591B4BB3677CQ43838770-1368806E-2F93-46D1-8292-9A6812FBF763Q48319736-B38C9582-E6AA-47A2-AD8A-BCC77A0DC4C6Q50860736-082F02D3-9588-48C5-9049-FEDC3F2663FE
P2860
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@ast
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@en
Hemorrhaging focal encephalitis under fingolimod
@nl
type
label
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@ast
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@en
Hemorrhaging focal encephalitis under fingolimod
@nl
prefLabel
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@ast
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@en
Hemorrhaging focal encephalitis under fingolimod
@nl
P2093
P1433
P1476
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
@en
P2093
P304
P356
10.1212/01.WNL.0000344567.51394.E3
P407
P577
2009-03-01T00:00:00Z